Vendor Endorsement Policy

LSC

The CEO Roundtable on Cancer often receives requests from vendors to formally endorse products and services in return for providing CEO Roundtable on Cancer members and/or entities accredited through the organization’s CEO Cancer Gold Standard program unique products, incentives, services, etc.

As a non-profit, vendor-neutral organization, The CEO Roundtable on Cancer does not formally endorse any product, service or company.

The CEO Roundtable on Cancer welcomes and encourages vendor inquiries and/or information exchange for the purpose of linking member companies, their employees and/or their family members to proven, value-added, health and wellness services and products.

However, vendor involvement and any resulting actions, when offered by The CEO Roundtable on Cancer are done so with the mutual and express understanding that The CEO Roundtable on Cancer does not proffer any formal endorsement, sanction, ratification, recommendation or seal of approval to any product or enterprise, for-profit or not-for-profit.

October 10 2008
CEO Roundtable on Cancer Offers “Common Language” to Jump Start Cancer Clinical Trials
- Partnership with National Cancer Institute, academic centers and industry could speed new therapies to cancer patients -
Read More

Standard Terms of Agreement for Research Trial (START) Clauses

StartCover.png Access to standardized legal language for Key elements can increase the efficiency of contract negotiations, resulting in reduced costs and accelerating the entry of new therapies into clinical trials.

Print Page Email Page to Friend Feedback
© 2010 by Life Sciences Consortium  All rights reserved.